Cancer News: Breast
A diagnosis of high cholesterol led to reduced mortality and improved survival in lung, breast, prostate and bowel cancer, a new researches reveals.
Physical activity improved subjective memory in breast cancer survivors, alleviating stress, a new study reports.
Breast cancer survivors who did acupressure over six weeks reduced fatigue, the most common long-term effects of breast cancer treatment.
Breast cancer patients treated with aromatase inhibitors who continued smoking had a three times higher risk of recurrence of breast cancer, a study shows.
Breast conserving therapy was associated with a higher risk of metastasis compared to mastectomy in early breast cancer patients, younger than 45 years old.
Treating early breast cancer patients with a shorter course of whole breast radiation induced the same outcomes as the longer course, a study reveals.
Postmenopausal breast cancer patients had a 34% lower risk of recurrence after receiving hormone therapy letrozole from 5 to 10 years, a new study shows.
Exercise reduced symptoms of neuropathy due to chemotherapy in cancer patients, investigators report.
Novartis halted early the clinical trial of the experimental breast cancer drug LEE011 in combination with letrozole due to positive results, the company announced.
Pembrolizumab (Keytruda) induced promising clinical activity in heavily pretreated patients with advanced triple-negative breast cancer.
A breast cancer combination treatment improved progression-free survival but not other outcomes, a new phase 3 study showed.
The patient’s age and the type of breast cancer surgery affects the outcomes in breast cancer patients, a new Danish study reveals.
Breast cancer patients treated with aromatase inhibitors, hormone-therapy drugs, were not in increased risk of fatal cardiovascular events, new study reports.
Monitoring for heart damage should be regular in breast cancer patients undergoing treatment with trastuzumab-containing regimens, a new study says.
Following a low fat diet increased breast cancer overall survival from diagnosis in postmenopausal women, a new study finds.
Women treated for ductal carcinoma in situ (DCIS) receiving delayed radiation treatment were at risk developing malignant breast tumors, a new study shows.
Exemestane (Aromasin) plus ovarian function suppression (OFS) proved to be more beneficial for breast cancer patients than tamoxifen with or without OFS.
Removing the second, healthy breast rose from 4% in breast cancer patients in 2002 to nearly 13% in 2012. However, this removal will not reduce the risk of dying.
Genomic testing can be used to help accurately select early breast cancer patients who can safely be spared chemotherapy, a new study shows.
A meta-analysis revealed that dose-dense adjuvant chemotherapy significantly improved overall survival in premenopausal women with breast cancer.
Tumors of breast cancer patients either shrunk or disappeared after treatment with a combination of lapatinib and trastuzumab.
Focusing postoperative radiotherapy around tumor containing cells has fewer long-term side effects and low recurrence rate in breast cancer patients.
A retrospective study reports that a high white blood cell ratio in early stage breast cancer patients is linked to an increased risk of disease recurrence.
A new study reports that undergoing double mastectomy did not improve the quality of life of breast cancer patients.
Childhood Hodgkin's lymphoma survivors are at risk of breast cancer say researchers, adding that early screening reduces risk of breast cancer death.
US regulators approved earlier than scheduled palbociclib in combination with fulvestrant for the treatment of some cases of breast cancer.
Breast or thyroid cancer survivors are more likely to develop the other type later in life compared to women with no breast or thyroid cancer history.
Breast reconstruction with fat injection proved to be safe for women with recurrent breast cancer, according to a new study.
One large study assessing breast cancer survivors’ smoking habits both before and after diagnosis reports that quitting smoking after diagnosis lowers risk of death.
A new analysis reveals that ER-positive (ER+) breast cancer may return even after more than 24 years of follow-up.